financetom
Business
financetom
/
Business
/
Cyberark Software Posts 'Strong' Q4 Results, Beats Expectations With 30% ARR Growth, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cyberark Software Posts 'Strong' Q4 Results, Beats Expectations With 30% ARR Growth, Morgan Stanley Says
Feb 14, 2025 9:06 AM

11:41 AM EST, 02/14/2025 (MT Newswires) -- CyberArk Software ( CYBR ) reported "strong" Q4 results with 30% organic annual recurring revenue growth, surpassing expectations, Morgan Stanley said in a report on Friday.

The information security company reported Q4 non-GAAP net income of $0.80 per diluted share Thursday, slightly down from $0.81 last year, while revenue rose to $314.4 million from $223.1 million.

"On the call, management doubled down on their position as the Identity Security platform for humans (employees), machines and now AI agents, which represents the next frontier and [total addressable market] expansion opportunity," Morgan Stanley said.

CyberArk's broader platform continues to gain traction, with 50% of new customers purchasing multiple products. Secrets Manager, or Conjur, showed strong Q4 momentum and has the potential to become a $100 million ARR product, and the acquisition of Zilla Security enhances CyberArk's coverage of the three core pillars of Identity Security-Access Management, Privileged Access, and Identity Governance & Administration, the report said.

The company's upcoming analyst day on Feb. 24, is expected to be a positive catalyst, likely introducing new three-year targets through 2028, the brokerage said.

Morgan Stanley kept and equal-weight rating on CyberArk, and raised its price target to $390 from $316.

"[W]e revise our top and bottom line estimates to account for business trends remaining healthy and potential upside from machine identity adoption over the next few years," the brokerage said.

Price: 405.48, Change: -8.83, Percent Change: -2.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ATN International Shares Decline on Q1 Results, Full-year Guidance Revision
ATN International Shares Decline on Q1 Results, Full-year Guidance Revision
Apr 25, 2024
01:54 PM EDT, 04/25/2024 (MT Newswires) -- ATN International ( ATNI ) shares were down nearly 35% in recent Thursday trading following the company's Q1 earnings late Wednesday. ATN International ( ATNI ) booked a Q1 diluted loss of $0.50 per share, widening from $0.44 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.08....
Joby Aviation Collaborates With Abu Dhabi Agencies to Establish, Scale Air Taxi Service
Joby Aviation Collaborates With Abu Dhabi Agencies to Establish, Scale Air Taxi Service
Apr 25, 2024
01:50 PM EDT, 04/25/2024 (MT Newswires) -- Joby Aviation ( JOBY ) said Thursday it has signed a multilateral memorandum of understanding with three Abu Dhabi government agencies for the establishment and scaling of air taxi services. The agencies include the Abu Dhabi's Department of Municipalities and Transport, the Department of Culture and Tourism, and the Abu Dhabi Department of...
Lam Research Expects 2024 To Be A 'Transition Year,' 4 Analysts Provide Key Q3 Takeaways
Lam Research Expects 2024 To Be A 'Transition Year,' 4 Analysts Provide Key Q3 Takeaways
Apr 25, 2024
Lam Research Corporation ( LRCX ) reported better-than-expected results for its fiscal third quarter. Here are some key analyst takeaways from the results, which came amid an exciting earnings season. Mizuho Securities analyst Vijay Rakesh reiterated a Buy rating, while raising the price target from $935 to $960. Raymond James analyst Srini Pajjuri maintained an Outperform rating and price target...
FSD Pharma Says Celly Nutrition Partners with Six+One for US Launch of Dietary Supplement
FSD Pharma Says Celly Nutrition Partners with Six+One for US Launch of Dietary Supplement
Apr 25, 2024
01:50 PM EDT, 04/25/2024 (MT Newswires) -- FSD Pharma ( HUGE ) said Thursday that Celly Nutrition has partnered with branding agency Six+One to collaborate on the launch of its dietary supplement unbuzzd in the US. As part of the collaboration, Six+One will undertake brand development for unbuzzd, including establishing a brand personality, creating a visual identity and website building,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved